Pyrrolotriazine kinase inhibitors
US7173031B2 · kind B2 · utility
16Cited by
29References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 24, 2005 |
| Grant date | Feb 6, 2007 |
| Priority date | — |
| Expiry date | Jun 24, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In general, the instant invention comprises compounds of Formulas I and IIincluding pharmaceutically acceptable salts thereof. The compounds of the invention are useful as protein kinase inhibitors and therefore are useful for treating cancer and other protein kinase mediated diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.